ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 3079

The Characteristic Features of the Patients with Deficiency of Adenosine Deaminase 2 (DADA2)

Abdulsamet Erden1, Ezgi Deniz Batu2, Ekim Z. Taskiran3, Hafize Emine Sonmez2, Alper Sari1, Berkan Armagan1, Levent Kilic1, Zehra Serap Arıcı4, Yelda Bilginer5, Ali Akdogan1, Omer Karadag1, Umut Kalyoncu1 and Seza Ozen6,7, 1Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, 2Pediatric Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, 3Department of Medical Genetics, Hacettepe University Faculty of Medicine, ANKARA, Turkey, 4Departments of Pediatric Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, 5Departments of Pediatric Nephrology and Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, 6Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey, 7Department of Pediatrics, Division of Rheumatology, Hacettepe University Faculty of Medicine, ANKARA, Turkey

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Vasculitis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Session Title: Miscellaneous Rheumatic and Inflammatory Diseases II

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive autoinflammatory disease resulting from a loss-of-function mutation in Cat Eye Syndrome Chromosome Region Candidate 1 (CERC1) gene encoding for ADA2 protein. Patients present with systemic inflammation and vasculopathy.   In this study, we presented the characteristics of the pediatric and adult DADA2 cases.

Methods: Clinical and laboratory features of thirteen DADA2 patients (8 Male, 5 Female), diagnosed at Hacettepe University Pediatric and Adult Rheumatology Department between 2014-2016, have been summarized. Mutations in CECR1 were detected by Sanger sequencing.

Results: Ten patients were homozygous for G47R; one was compound heterozygous for G47R and G47V while two patients were heterozygous for G47R mutation. Nine patients had been followed up with the diagnosis of polyarteritis nodosa (PAN). There was consanguinity in 6 cases, and 2 were siblings. The median (min-max) age at onset of the symptoms and diagnosis was 6.5 (1.5-35) and 17 (3-45) years, respectively. All patients suffered from recurrent episodes of fever and abdominal pain with elevated acute phase reactants. Livedo reticularis (n= 12, (92.3%)), erythema nodosum (n=6, (46.2%)), raynaud’s phenomenon (n=4, (30.8%)) and digital ulcers (n=1, (7.7%)) were common skin manifestations. Neurological and musculoskeletal involvement was;  in the form of myalgia (n = 13, (100%)), arthralgia (n= 12, (92.3%)), arthritis (n= 9, (69.2%)), peripheral neuropathy (n=7, (53.8%)), ischemic stroke (n=7, (53.8%)), strabismus (n=5, (38.5%)), hemorrhagic stroke (n=2, (15.4%)), spinal cord atrophy (n = 1, (7.7%)), and optic neuritis (n = 1, (7.7%)) . One patient had been diagnosed with core myopathy through co-incidental muscle biopsy finding. Eight patients had aneurysms in medium-sized abdominal visceral arteries (hepatic artery, renal artery, and superior mesenteric artery). As renal involvement, one patient had focal segmental glomerulosclerosis (collapsing variant), one mesangial proliferative glomerulonephritis, and one had renal amyloidosis. There was testicular involvement in 3 (23.1%) patients and one had testicular torsion. One patient had intestinal perforation. Two adult patients died soon after diagnosis of DADA2. One patient was asymptomatic on only colchicine for almost 10 years. Rest of the patients responded well to etanercept therapy.

Conclusion: ADA2 deficiency is a recently defined disease and the data about its phenotype increases with the introduction of new cases with different symptoms. Stroke, peripheral neuropathy, livedo reticularis, myalgia, recurrent episodes of fever and recurrent abdominal pain are important findings to suspect DADA2. In our series, we have described for the first time spinal cord atrophy, core myopathy, and mesangial proliferative glomerulonephritis in DADA2 patients.

 


Disclosure: A. Erden, None; E. D. Batu, None; E. Z. Taskiran, None; H. E. Sonmez, None; A. Sari, None; B. Armagan, None; L. Kilic, None; Z. S. Arıcı, None; Y. Bilginer, None; A. Akdogan, None; O. Karadag, Pfizer Inc, 2,Abbvie, 2,Abbvie, 5,BMS, 5,MSD, 5,Pfizer Inc, 5,Roche Pharmaceuticals, 5,UCB, 5,Sanofi-Aventis Pharmaceutical, 5; U. Kalyoncu, None; S. Ozen, None.

To cite this abstract in AMA style:

Erden A, Batu ED, Taskiran EZ, Sonmez HE, Sari A, Armagan B, Kilic L, Arıcı ZS, Bilginer Y, Akdogan A, Karadag O, Kalyoncu U, Ozen S. The Characteristic Features of the Patients with Deficiency of Adenosine Deaminase 2 (DADA2) [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/the-characteristic-features-of-the-patients-with-deficiency-of-adenosine-deaminase-2-dada2/. Accessed February 2, 2023.
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-characteristic-features-of-the-patients-with-deficiency-of-adenosine-deaminase-2-dada2/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences